Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Huijuan Cui
Observed names:
H Cui,
H.-J. Cui,
Hui Cui,
Hui Juan Cui,
Hui-Juan Cui,
Hui-juan Cui,
Hui‑Juan Cui
show all 7
Institution:
China-Japan Friendship Hospital
Observed institutions:
Ningbo University,
Beijing University of Chinese Medicine,
Changzhi Medical College,
Wenzhou Medical University,
China-Japan Friendship Hospital,
Chinese PLA General Hospital,
First Hospital of Jilin University,
Wenzhou Polytechnic,
Wenzhou Medical University Renji College
show all 9
ORCID:
0000-0003-2900-0461
Observed ORCID:
0000-0003-2900-0461
OpenAlex ID:
A5019384409
Traditional Chinese medicine in the era of immune checkpoint inhibitor: theory, development, and future directions
2023
·
Yi-xuan Yu
, Shuo Wang
, et al.
·
Chinese Medicine
·
52
PDF
Update review of skin adverse events during treatment of lung cancer and colorectal carcinoma with epidermal growth receptor factor inhibitors
2018
·
Yanmei Peng
, Qiang Li
, et al.
·
BioScience Trends
·
38
PDF
Serum hepatic enzyme manifestations in patients with severe acute respiratory syndrome: Retrospective analysis
2004
·
Hui-Juan Cui
, Xiao-Lin Tong
, et al.
·
World Journal of Gastroenterology
·
28
PDF
Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of hepatocellular carcinoma (HCC)
2024
·
Yujie Pan
, Yunkuo Li
, et al.
·
Biomedicine & Pharmacotherapy
·
27
Efficacy and Safety of Antivascular Endothelial Growth Factor (Anti-VEGF) in Treating Neovascular Age-Related Macular Degeneration (AMD): A Systematic Review and Meta-analysis
2022
·
Xiaobei Yin
, Ting He
, et al.
·
Journal of Immunology Research
·
22
PDF
Apatinib to combat EGFR-TKI resistance in an advanced non-small cell lung cancer patient with unknown EGFR status: a case report
2017
·
Yanmei Peng
, Huijuan Cui
, et al.
·
OncoTargets and Therapy
·
22
PDF
The efficacy and safety of immune checkpoint inhibitors in non-small cell lung cancer patients of different age groups: a meta-analysis
2019
·
S.-Y. Zheng
, H.-J. Cui
, et al.
·
Clinical & Translational Oncology
·
20
PDF
Hyper-Methylated Hub Genes of T-Cell Receptor Signaling Predict a Poor Clinical Outcome in Lung Adenocarcinoma
2022
·
Zixin Hu
, Chongxiang Xue
, et al.
·
Journal of Oncology
·
17
PDF
Mapping the rapid growth of multi-omics in tumor immunotherapy: Bibliometric evidence of technology convergence and paradigm shifts
2025
·
Huijing Dong
, Xinmeng Wang
, et al.
·
Human Vaccines & Immunotherapeutics
·
13
PDF
Pathological diagnosis and treatment outcome of gastric metastases from small cell lung cancer: A case report
2019
·
Yanmei Peng
, Qing Liu
, et al.
·
Oncology Letters
·
10
PDF
Treatment of severe rash caused by crizotinib with both traditional Chinese medicine and Western medicine: Two case reports and literature review
2018
·
Shu-Yue Zheng
, Wen Shen
, et al.
·
Medicine
·
10
Effectiveness of afatinib after ineffectiveness of gefitinib in an advanced lung adenocarcinoma patient with a single EGFR exon 20 S768I mutation: a case report
2018
·
Hua Duan
, Yanmei Peng
, et al.
·
OncoTargets and Therapy
·
10
PDF
Association of rs3787016 in Long Non-coding RNAs POLR2E and rs2910164 in MiRNA-146a with Prostate Cancer: A Systematic Review and Meta-analysis.
2018
·
Shuaishuai Huang
, Hui Cui
, et al.
·
PubMed Central
·
9
PDF
Gegen Qinlian Tablets attenuate immune-related adverse events in NSCLC patients: A multi-center randomized controlled trial in China
2025
·
Xingyu Lu
, Aolin Wang
, et al.
·
Phytomedicine
·
8
Treatment-related adverse events of immune checkpoint inhibitors combined with angiogenesis inhibitors in advanced lung cancer: A systematic review and meta-analysis
2023
·
Yumin Zheng
, Huijing Dong
, et al.
·
International Immunopharmacology
·
8
[Treatment of EGFRIs-related Skin Adverse Reactions by Zhiyang Pingfu Lotion].
2017
·
Yan-Mei Peng
, Hui-Juan Cui
, et al.
·
PubMed
·
8
Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Cancer and Hepatitis B or C: A Systematic Review and Meta-Analysis
2023
·
Huijing Dong
, Chongxiang Xue
, et al.
·
Journal of Oncology
·
7
PDF
Management of Regorafenib-Induced Hand-Foot Skin Reaction with Topical Chinese Medicine and Urea Ointment: A Case Report and Literature Review
2025
·
Zhe-Ning Liu
, Yu-Lei Shen
, et al.
·
OncoTargets and Therapy
·
6
Treatment patterns and clinical outcomes in 157 patients with extensive-stage small cell lung cancer: real-world evidence from a single-center retrospective study
2023
·
Yumin Zheng
, Kexin Tan
, et al.
·
Frontiers in Oncology
·
6
PDF
Chrono-immunotherapy’s current and future optimization strategies: immunotherapy timing in line with the circadian rhythm brings longer survival benefits
2026
·
Daiwei Liu
, Zhanlin Li
, et al.
·
Frontiers in Immunology
·
5
PDF
Synergistic Triple-Modal Nanoplatform Integrating Fluorescence Imaging and Chemo-Photothermal/Photodynamic Therapy for Targeted Cancer Treatment
2026
·
Sahresh Majeed
, Yumo Liu
, et al.
·
ACS Applied Bio Materials
·
5
Comparative analysis of high-intensity resistance training and blood flow restriction training on enhancing upper limb muscle strength and mass
2025
·
Jianli Zhang
, Hualong Chang
, et al.
·
Frontiers in Physiology
·
5
The effect of Baduanjin on postoperative activity tolerance, lung function and negative emotions in patients with lung cancer: a systematic review and meta-analysis
2025
·
Daixi Wu
, Jia Li
, et al.
·
Supportive Care in Cancer
·
5
Efficacy and safety of Shengjiang Xiexin decoction on irinotecan-induced diarrhea in small cell lung cancer patients: a multicenter, randomized, double-blind, placebo-controlled trial
2024
·
Chao Deng
, Qing Liu
, et al.
·
Chinese Medicine
·
5
PDF
[Treatment of Epidermal Growth Factor Receptor Inhibitors Associated Adverse Skin Reactions by Zhiyang Pingfu Liquid: a Clinical Study].
2015
·
Hong-yan Wang
, Chao Zou
, et al.
·
PubMed
·
5
Show more works
View as search
Works count:
48
Citation count:
381
H-index:
10
I10-index:
12
Year
Topic
Type